Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 3Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Temozolomide 11Radiotherapy 10Cisplatin 4Carmustine 4Vincristine 3Surgical Procedures, Operative 3Methotrexate 3Lomustine 3Chlorotoxin 3Carboplatin 3Thiotepa 2Etoposide 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Amplified Fragment Length Polymorphism Analysis 2lonafarnib 1interleukin-4-Pseudomonas exotoxin 1Verteporfin 1Valproic Acid 1Tranexamic Acid 1Tf-CRM107 1Tamoxifen 1Procarbazine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Neoadjuvant Therapy 1Metformin 1Metabolism 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Astrocytoma × Aminolevulinic Acid × Clear all
NCT02119338 2017-01-06

5-ALA in Recurrent Glioma

St. Joseph's Hospital and Medical Center, Phoenix

Phase NA Unknown
60 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡